Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Multiple Sclerosis

  Free Subscription


Articles published in Rev Neurol

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    August 2021
  1. MECA-LALLANA V, Rodriguez-Antiguedad A, Llaneza MA, Meca-Lallana JE, et al
    [Plasma determination of neurofilaments as biomarkers in multiple sclerosis: conclusions of the EMotion Forum].
    Rev Neurol. 2021;73:101-110.
    PubMed     Abstract available


    June 2021
  2. FERNANDEZ O, Montalban X, Aladro Y, Alonso A, et al
    13th Post-ECTRIMS Meeting: review of the new developments presented at the 2020 ECTRIMS Congress (I).
    Rev Neurol. 2021;72:397-406.
    PubMed     Abstract available


    April 2021
  3. COSTA FROSSARD-FRANCA L, Garcia-Dominguez JM, Moreno-Torres I, Fortun J, et al
    [Vaccination against SARS-CoV-2 in patients with multiple sclerosis].
    Rev Neurol. 2021;72:250-260.
    PubMed     Abstract available


    March 2021
  4. BENITO-VILLALVILLA D, Lopez de Uralde-Villanueva I, Rios-Leon M, Alvarez-Melcon AC, et al
    [Effectiveness of motor imagery in patients with multiple sclerosis: a systematic review].
    Rev Neurol. 2021;72:157-167.
    PubMed     Abstract available


    January 2021
  5. CRISTIANO E, Patrucco L, Ysrraelit MC, Alonso R, et al
    [Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis].
    Rev Neurol. 2021;72:23-32.
    PubMed     Abstract available


    August 2020
  6. CARDENAS-ROBLEDO S, Otero-Romero S, Montalban X, Tintore M, et al
    [Prevalence and impact of comorbidities in patients with multiple sclerosis].
    Rev Neurol. 2020;71:151-158.
    PubMed     Abstract available


    July 2020
  7. GARCIA-ESTEVEZ DA, Fraga-Gonzalez C, Ramos-Pacho ME, Lopez-Diaz LM, et al
    [The prevalence of multiple sclerosis in the city of Ourense, Galicia, in the north-west of the Iberian Peninsula].
    Rev Neurol. 2020;71:19-25.
    PubMed     Abstract available


    May 2020
  8. COSTA-FROSSARD L, Moreno-Torres I, Meca-Lallana V, Garcia-Dominguez JM, et al
    [EMCAM (Multiple Sclerosis Autonomous Community of Madrid) document for the management of patients with multiple sclerosis during the SARS-CoV-2 pandemic].
    Rev Neurol. 2020;70:329-340.
    PubMed     Abstract available


    January 2020
  9. JIMENEZ-ZAMBRANO J, Zambrano-Llaguno K, Acuna-Chong MG
    Social anxiety disorder among patients with multiple sclerosis: a population-based case-control study in Ecuador.
    Rev Neurol. 2020;70:45-52.
    PubMed     Abstract available


    December 2019
  10. OREJA-GUEVARA C, Garcia-Merino JA, Saiz A, Rodriguez-Antiguedad A, et al
    [Recommendations for the use of cladribine tablets in recurring multiple sclerosis].
    Rev Neurol. 2019;69.
    PubMed     Abstract available


    July 2019
  11. DIEGUEZ-VARELA C, Lion-Vazquez S, Fraga-Bau A, Rodriguez-Acevedo B, et al
    [Intermittent theta-burst transcranial magnetic stimulation for the treatment of spasticity in patients with recurring multiple sclerosis: the results of a double-blind randomised clinical trial].
    Rev Neurol. 2019;69:45-52.
    PubMed     Abstract available


  12. PEREZ-CARMONA N, Fernandez-Jover E, Sempere AP
    [Epidemiology of multiple sclerosis in Spain].
    Rev Neurol. 2019;69:32-38.
    PubMed     Abstract available


    May 2019
  13. MORENO-VERDU M, Ferreira-Sanchez MR, Cano-de-la-Cuerda R, Jimenez-Antona C, et al
    [Efficacy of virtual reality on balance and gait in multiple sclerosis. Systematic review of randomized controlled trials].
    Rev Neurol. 2019;68:357-368.
    PubMed     Abstract available


    March 2019
  14. PEREZ-ALVAREZ AI, Garcia-Rua A, Suarez-Santos P, Castanon-Apilanez M, et al
    [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index. Reply].
    Rev Neurol. 2019;68:269-270.
    PubMed    


  15. VALENCIA-CALDERON C
    [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index].
    Rev Neurol. 2019;68:268-269.
    PubMed    


  16. MAIA C, Costa A, Abreu P, Sa MJ, et al
    All-cause hospitalizations in multiple sclerosis patients.
    Rev Neurol. 2019;68:229-235.
    PubMed     Abstract available


    February 2019
  17. PADRON-GONZALEZ AA, Gonzalez-Costa M
    [Glutamate, hypothalamus-hypophysis-adrenal axis and clinical manifestations in multiple sclerosis].
    Rev Neurol. 2019;68:134.
    PubMed    


    December 2018
  18. ZAYAS-GARCIA S, Cano-de-la-Cuerda R
    [Mobile applications related to multiple sclerosis: a systematic review].
    Rev Neurol. 2018;67:473-483.
    PubMed     Abstract available


  19. PEREZ-ALVAREZ AI, Garcia-Rua A, Suarez-Santos P, Castanon-Apilanez M, et al
    [Appraisal of cerebral atrophy in multiple sclerosis by means of the corpus callosum index].
    Rev Neurol. 2018;67:417-424.
    PubMed     Abstract available


    November 2018
  20. PEDRAZ B, Sammer G
    The importance of glutamate in the neuro-endocrinological functions in multiple sclerosis, related to fatigue.
    Rev Neurol. 2018;67:387-393.
    PubMed     Abstract available


  21. ROBLES-CEDENO R, Ramio-Torrenta L
    [Cladribine in the treatment of relapsing multiple sclerosis].
    Rev Neurol. 2018;67:343-354.
    PubMed     Abstract available


    September 2018
  22. MALLADA-FRECHIN J, Meca-Lallana V, Barrero F, Martinez-Gines ML, et al
    [Efficacy and safety of fingolimod in routine clinical practice in patients with relapsing-remitting multiple sclerosis in Spain: an intermediate analysis of the MS NEXT study].
    Rev Neurol. 2018;67:157-167.
    PubMed     Abstract available


    August 2018
  23. LABBE T, Ciampi E, Cruz JP, Zurita M, et al
    Functional magnetic resonance imaging in the study of multiple sclerosis.
    Rev Neurol. 2018;67:91-98.
    PubMed     Abstract available


    July 2018
  24. FERNANDEZ O, Tintore M, Saiz A, Calles-Hernandez MC, et al
    [Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (II)].
    Rev Neurol. 2018;67:50-62.
    PubMed     Abstract available


  25. FERNANDEZ O, Tintore M, Saiz A, Calles-Hernandez MC, et al
    [Review of the novelties from the 2017 ECTRIMS Congress, presented at the 10th Post-ECTRIMS Meeting (I)].
    Rev Neurol. 2018;67:15-27.
    PubMed     Abstract available


    June 2018
  26. JUANATEY A, Blanco-Garcia L, Tellez N
    Ocrelizumab: its efficacy and safety in multiple sclerosis.
    Rev Neurol. 2018;66:423-433.
    PubMed     Abstract available


  27. EICHAU S, Lopez-Ruiz R, Ruiz-Pena JL, Paramo MD, et al
    [Vitiligo with Koebner phenomenon in a patient with multiple sclerosis treated with alemtuzumab].
    Rev Neurol. 2018;66:395-396.
    PubMed    


    May 2018
  28. GONZALEZ-GOMEZ A, Garcia-Ben A, Soler-Garcia A, Garcia-Basterra I, et al
    [Analysis of the quantitative differences in the thickness of the retinal nerve fibre layer between time-domain and spectral-domain optical coherence tomography in patients with relapsing-remitting multiple sclerosis].
    Rev Neurol. 2018;66:297-302.
    PubMed     Abstract available


    April 2018
  29. PEREZ-MIRALLES FC
    Daclizumab in multiple sclerosis.
    Rev Neurol. 2018;66:271-282.
    PubMed     Abstract available


  30. RIO J
    [New drugs for the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:253.
    PubMed    


    March 2018
  31. PULIDO I, Gomes I, Rodrigues J, Guerreiro T, et al
    [Multiple sclerosis in continental Portugal: analysis of spatio-temporal clusters and spatial variations in time trends of hospitalised patients between 2002 and 2013].
    Rev Neurol. 2018;66:182-188.
    PubMed     Abstract available


    January 2018
  32. MIDAGLIA L, Mora L, Mulero P, Sastre-Garriga J, et al
    [Rituximab: its efficacy, effectiveness and safety in the treatment of multiple sclerosis].
    Rev Neurol. 2018;66:25-32.
    PubMed     Abstract available


    September 2017
  33. LOPEZ-ALAVA S, Aliri J, Olascoaga J, Sistiaga A, et al
    [Psychosocial factors and cognitive performance in multiple sclerosis: gender differences].
    Rev Neurol. 2017;65:216-222.
    PubMed     Abstract available


    August 2017
  34. LANDER B, Alvarado M, Alvarez IC, Armas E, et al
    [Venezuelan consensus guidelines on the use of magnetic resonance in diagnosis and follow up of patients with multiple sclerosis].
    Rev Neurol. 2017;65:117-126.
    PubMed     Abstract available


    June 2017
  35. JIMENEZ-MORALES RM, Herrera-Jimenez LF, Macias-Delgado Y, Perez-Medinilla YT, et al
    [Cognitive training combined with aerobic exercises in multiple sclerosis patients: a pilot study].
    Rev Neurol. 2017;64:489-495.
    PubMed     Abstract available


    May 2017
  36. ALCALA-VICENTE C, Perez-Miralles FC, Gascon-Gimenez F, Bosca-Blasco I, et al
    [Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice].
    Rev Neurol. 2017;64:445-453.
    PubMed     Abstract available


    March 2017
  37. ORTIZ P, Bareno J, Cabrera L, Rueda K, et al
    [Magnetic resonance imaging with gadolinium in the acute phase of relapses in multiple sclerosis].
    Rev Neurol. 2017;64:241-246.
    PubMed     Abstract available


    February 2017
  38. DUQUE P, Oltra-Cucarella J, Fernandez O, Sepulcre J, et al
    [Brief Neuropsychological Battery for multiple sclerosis. Normative data stratified by age and educational level].
    Rev Neurol. 2017;64:97-104.
    PubMed     Abstract available


    December 2016
  39. COLLADO-VAZQUEZ S, Carrillo JM, Cano-de-la-Cuerda R
    [Multiple sclerosis in literature, cinema and television].
    Rev Neurol. 2016;63:547-556.
    PubMed     Abstract available


    October 2016
  40. FERNANDEZ JIMENEZ-ORTIZ H, Reche-Sainz JA, Villarrubia-Torcal B, Toledano-Fernandez N, et al
    [Appraisal of the formation of afterimages by means of a new computer application in patients with demyelinating optic neuropathies].
    Rev Neurol. 2016;63:337-344.
    PubMed     Abstract available


    August 2016
  41. LOPEZ-MARTIN D, Martinez-Anton J
    [Optic neuritis in childhood. A pediatric series, literature review and treatment approach].
    Rev Neurol. 2016;63:103-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: